ERBB2 and breast cancer: Importantly, two recent studies showed that basal-like and HER2+ BC cells have a higher DNL rate when they grow in brain metastatic site rather than in primary one, and the DNL signature, characterized by increased cholesterol species and structural lipids, governs their ability to metastasize exclusively in the brain [36, 37].